Literature DB >> 21215465

Enhanced complement consumption in neuromyelitis optica and Behçet's disease patients.

Erdem Tüzün1, Murat Kürtüncü, Recai Türkoğlu, Sema Içöz, Münevver Pehlivan, Omer Birişik, Mefküre Eraksoy, Gulsen Akman-Demir.   

Abstract

The complement system is essential in the pathogenesis of inflammatory central nervous system disorders. To investigate the involvement of complement pathways in neuromyelitis optica (NMO), levels of breakdown products for classical (C4d), alternative (FBb) and common (sC5b-9) pathways were measured in the sera of 28 NMO and control patients (30 Behçet's disease (BD), 29 multiple sclerosis (MS)) and 31 healthy controls by ELISA. Classical and/or alternative pathway consumption was enhanced in NMO and BD patients as compared to MS patients and healthy controls. Our results suggest that NBD and NMO differ from MS by the predominance of complement system involvement.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21215465     DOI: 10.1016/j.jneuroim.2010.11.010

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  7 in total

Review 1.  [Neuromyelitis optica].

Authors:  B Wildemann; S Jarius; F Paul
Journal:  Nervenarzt       Date:  2013-04       Impact factor: 1.214

Review 2.  Targeting Neuromyelitis Optica Pathogenesis: Results from Randomized Controlled Trials of Biologics.

Authors:  Laura Cacciaguerra; Paola Tortorella; Maria A Rocca; Massimo Filippi
Journal:  Neurotherapeutics       Date:  2021-04-28       Impact factor: 6.088

Review 3.  Serum and Cerebrospinal Fluid Biomarkers in Neuromyelitis Optica Spectrum Disorder and Myelin Oligodendrocyte Glycoprotein Associated Disease.

Authors:  Alessandro Dinoto; Elia Sechi; Eoin P Flanagan; Sergio Ferrari; Paolo Solla; Sara Mariotto; John J Chen
Journal:  Front Neurol       Date:  2022-03-23       Impact factor: 4.003

4.  Neuromyelitis Optica Spectrum Disorder and Autoimmune Rheumatological Diseases: A Report of Two Cases and Literature Review.

Authors:  Mohannad Faisal; Ahmad Matarneh; Israa Alshahwani; Omar Al-Allaf; Abdul-Wahab Al-Allaf
Journal:  Cureus       Date:  2022-06-20

Review 5.  The Immunology of Neuromyelitis Optica-Current Knowledge, Clinical Implications, Controversies and Future Perspectives.

Authors:  Michalina Jasiak-Zatonska; Alicja Kalinowska-Lyszczarz; Slawomir Michalak; Wojciech Kozubski
Journal:  Int J Mol Sci       Date:  2016-03-02       Impact factor: 5.923

Review 6.  Soluble Membrane Attack Complex: Biochemistry and Immunobiology.

Authors:  Scott R Barnum; Doryen Bubeck; Theresa N Schein
Journal:  Front Immunol       Date:  2020-11-10       Impact factor: 7.561

7.  Relationship between the Clinical Characteristics in Patients with Neuromyelitis Optica Spectrum Disorders and Clinical Immune Indicators: A Retrospective Study.

Authors:  Linjun Cai; Ziyan Shi; Hongxi Chen; Qin Du; Ying Zhang; Zhengyang Zhao; Jiancheng Wang; Yanling Lang; Lingyao Kong; Hongyu Zhou
Journal:  Brain Sci       Date:  2022-03-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.